Silencing of HTR1B and reduced expression of EDN1 in human lung cancers, revealed by methylation-sensitive representational difference analysis
- 8 November 2001
- journal article
- Published by Springer Nature in Oncogene
- Vol. 20 (51) , 7505-7513
- https://doi.org/10.1038/sj.onc.1204940
Abstract
Aberrantly hypermethylated genes in human lung cancers were searched for by a genome scanning technique, methylation-sensitive-representational difference analysis (MS-RDA). A total of 59 DNA fragments were isolated as those methylated more heavily in either/both of two lung squamous cell carcinoma cell lines, EBC-1 and LK-2, than in a primary culture of normal human bronchial epithelium, NHBE. Thirty-four DNA fragments, whose hypermethylation was confirmed in primary squamous cell carcinomas, were sequenced. By database searches, 17 of them were shown to be located within 2 kb of putative CpG islands, and five of the 17 DNA fragments had transcribed regions of known genes in their vicinities. By RT-PCR of the five genes in the carcinoma cell lines and NHBE, decreased expression of HTR1B (5-hydroxytryptamine receptor 1B) and EDN1 (endothelin-1) was observed. Sequencing after bisulfite modification showed that the CpG island in the promoter region of HTR1B was hypermethylated, while that of EDN1 was not. Demethylation and re-expression of HTR1B were observed after treatment of LK-2 cells with 5-aza-2'-deoxycytidine. In primary lung cancers, decreased mRNA expression of HTR1B was observed in 11 of 20 cases, and that of EDN1 was in 16 of 20 cases. Immunohistochemical analysis of endothelin-1 confirmed that its immunoreactivity was reduced in squamous cell carcinoma cells compared with that in normal bronchial epithelial cells. Considering that endothelin-1 induces apoptosis in melanoma cells and that silencing of endothelin receptor B is observed in prostate cancers, its reduced expression was speculated to confer a growth advantage to lung cancer cells. MS-RDA was shown to isolate DNA fragments that are hypermethylated and silenced, such as HTR1B, and those whose expressions are altered and the methylation statuses outside the promoter region are altered, such as EDN1.Keywords
This publication has 22 references indexed in Scilit:
- CpG islands as gene markers in the human genomePublished by Elsevier ,2004
- CpG Islands in vertebrate genomesPublished by Elsevier ,2004
- Identification of Imprinted Loci by Methylation-Sensitive Representational Difference Analysis: Application to Mouse Distal Chromosome 2Genomics, 1999
- Cancer-epigenetics comes of ageNature Genetics, 1999
- Betaine Improves the PCR Amplification of GC-Rich DNA SequencesNucleic Acids Research, 1997
- Differential regulation of protease and extracellular matrix protein expression by transforming growth factor-beta 1 in non-small cell lung cancer cells and normal human bronchial epithelial cellsBiochimica et Biophysica Acta (BBA) - Gene Structure and Expression, 1997
- Reverse Electrophoresis to Concentrate DNA FractionsAnalytical Biochemistry, 1995
- Physiology and pharmacology of endothelinsMedicinal Research Reviews, 1992
- A human serotonin 1D receptor variant (5HT1D beta) encoded by an intronless gene on chromosome 6.Proceedings of the National Academy of Sciences, 1992
- Endothelins, peptides with potent vasoactive properties, are produced by human macrophages.The Journal of Experimental Medicine, 1990